Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Amplia Therapeutics ( (AU:ATX) ) has issued an announcement.
Amplia Therapeutics Limited has announced a change in the interests of a substantial holder, Acorn Capital Limited, which acts as an investment manager for various superannuation funds, institutional investor portfolios, and unit trusts. This change affects the voting power and number of securities held by Acorn Capital in Amplia Therapeutics. The announcement reflects a decrease in voting power from 8.91% to 7.70%, indicating a shift in Acorn Capital’s stake in the company, which may influence the company’s shareholder dynamics and decision-making processes.
More about Amplia Therapeutics
Average Trading Volume: 2,267,737
Technical Sentiment Signal: Sell
Current Market Cap: A$25.6M
See more insights into ATX stock on TipRanks’ Stock Analysis page.